Home Tags VepdegestrantWinsFDA

Tag: VepdegestrantWinsFDA

Vepdegestrant Wins FDA Nod for ER+ Breast Cancer

0
Vepdegestrant, a newly approved anti-cancer medication, has marked a significant development in the treatment of breast cancer. As of May 2026, Vepdegestrant, sold under the...

ARTIFICIAL INTELLIGENCE

TECHNOLOGY

WORLD NEWS

CANCER NEWS

PENTAGON FILES